Elranatamab Causes Recurrent Multi-Myeloma Clinical Response
Data shown at the 64th American Society of Haematology (ASH) conference in New Orleans demonstrates that elranatamab is effective and has a controllable effectiveness...
PAXLOVID, The First Oral COVID-19 Generic, Is WHO-Approved
The generic version of the COVID-19 oral antiviral therapy candidate nirmatrelvir has been approved by the World Health Organization Prequalification of Medicines Program (WHO...
Singapore Discovers Novel Diabetic Eye Disease Treatment
Researchers in Singapore have identified a brand-new therapeutic target called ADAM10 that may be used to treat people who have diabetic retinopathy (DR), a...
Stem Cell Transplantation May Halt Course of MS Impairment
An Italian study that was recently published in Neurology, the official journal of the American Academy of Neurology, suggests that hematopoietic stem cell transplants...
Major Government Spending Bill Covers FDA, Research Issues
Multiple provisions crucial to FDA operations and authority, in addition to clinical research sponsors and pharmaceutical manufacturers, are included in the year-end, must-pass government...
Funding of Millions of Pounds Towards Genomics Research
The benefits of earlier detection and quicker access to treatments will be felt by cancer patients as well as newborns with curable but uncommon...
First Gene Treatment For Early Bladder Cancer Okayed By FDA
The first gene therapy for non-muscle invasive bladder cancer (NMIBC) in individuals with high-risk carcinoma in situ (CIS) with or without papillary tumours has...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...